Information  X 
Enter a valid email address

Lekoil Limited (LEK)


Thursday 06 January, 2022

Lekoil Limited

Notification of legal claim

RNS Number : 6472X
Lekoil Limited
06 January 2022

6  January 2022

Lekoil Limited

("LEKOIL" or the "Company")

Notification of legal claim

LEKOIL (AIM: LEK), the oil and gas exploration and production company with a focus on Nigeria and West Africa, notes that it has been served with a writ of summons in the Grand Court of the Cayman Islands by Olalekan Akinyanmi (the "Claim") challenging the validity of Resolutions 8 and 9 which were duly passed at the Company's Annual General Meeting held on 21 December 2021.

Resolution 8 concerns the allotment of ordinary shares in the Company ("Shares") to settle accrued but unpaid fees to creditors who agree to take part or all of their fees in Shares. Resolution 9 concerns the allotment of Shares to enable the Company, if required pursuant to the terms of the Convertible Facility Agreement dated 2 September 2021, to issue Shares to the Lenders in respect of any outstanding amounts under the Convertible Facility Agreement.

The Company considers that the Claim is entirely without merit and will defend the Claim in the normal manner. Further updates in relation to the Claim will be made as appropriate.


The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.


For further information, please visit or contact:

SP Angel Corporate Finance LLP (Nominated Adviser and Joint Broker)

Jeff Keating / Stuart Gledhill


+44 20 3470 0470

Tennyson Securities (Joint Broker)

Peter Krens / Edward Haig-Thomas

+44 20 7186 9030


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t